查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1406808

勃起功能障碍治疗设备市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按类型、原因、最终用户、地区和竞争细分

Erectile Dysfunction Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Cause, By End-user, by region, and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年，全球勃起功能障碍治疗设备市场价值为 12 亿美元，预计在预测期内将出现令人印象深刻的增长，到 2028 年复合CAGR为7.90%。勃起功能障碍(ED)，也称为阳痿，是一种医疗状况其特征是持续无法达到或维持足以满足性行为的勃起。这是一个常见问题，可能影响所有年龄层的男性，但随着年龄的增长变得更加普遍。 ED 可能有生理和心理原因，并且会对男性的生活品质和自尊产生重大影响。当流向阴茎的血流量增加，导致其变得坚硬和勃起时，就会发生勃起。这个过程涉及神经、血管、荷尔蒙和心理因素的复杂相互作用。当此过程的任何部分出现中断时，都可能发生 ED。 ED 的诊断通常涉及全面的病史、身体检查，有时还需要进行其他检查，例如血液检查或影像检查，以识别潜在的身体原因。 ED 的治疗方案取决于根本原因，可能包括生活方式改变、心理因素咨询或治疗、药物（如威而钢等5 型磷酸二酯酶抑制剂）、真空勃起装置、阴茎植入物，或在某些情况下进行手术。

全球人口正在老化，老年人更有可能出现勃起功能障碍。随着老年人口比例的增加，对包括医疗器材在内的治疗的需求更高。医疗设备技术的持续创新和进步促进了更有效和微创的勃起功能障碍治疗设备的开发，使它们对患者和医疗保健提供者更具吸引力。人们对勃起功能障碍作为一种医疗状况的认识不断提高，再加上宣传工作和教育活动，鼓励个人寻求治疗，并鼓励医疗保健提供者提供更广泛的选择，包括设备。生活方式因素，如压力增加、不良饮食习惯和久坐生活，可能会导致勃起功能障碍。由于这些与生活方式相关的问题持续存在，对包括设备在内的治疗方案的需求仍然强劲。

主要市场驱动因素

市场概况
预测期 2024-2028
2022 年市场规模 12亿美元
2028 年市场规模 18.7亿美元
2023-2028 年CAGR 7.90%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

医疗器材技术的进步

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型（真空收缩装置、阴茎植入物、衝击波疗法等）
    • 按原因（血管疾病及糖尿病、神经系统疾病等）
    • 按最终使用者（医院和诊所、门诊手术中心等）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：亚太地区勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按原因
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国勃起功能障碍治疗设备
    • 印度勃起功能障碍治疗设备
    • 澳洲勃起功能障碍治疗设备
    • 日本勃起功能障碍治疗仪
    • 韩国勃起功能障碍治疗设备

第 7 章：欧洲勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按原因
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 8 章：北美勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按原因
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 9 章：南美洲勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按原因
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲勃起功能障碍治疗设备市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按类型
    • 按原因
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非勃起功能障碍治疗设备
    • 沙乌地阿拉伯勃起功能障碍治疗设备
    • 阿联酋勃起功能障碍治疗设备

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 13 章：全球勃起功能障碍治疗设备市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第 15 章：大环境分析

第16章：竞争格局

  • 波士顿科学公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 康乐保公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • Zephyr 手术植入物
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 欧文芒福德有限公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 奥古斯塔医疗系统
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 斯托兹医疗股份公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 蒂姆医疗技术公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 埃拉特 AB
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 阿尔玛雷射有限公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis
  • 富利医疗股份有限公司
    • Business Overview
    • Company Snapshot
    • Products & Services
    • Financials (In case of listed companies)
    • Recent Developments
    • SWOT Analysis

第 17 章：策略建议

第 18 章：关于我们与免责声明

简介目录
Product Code: 19561

Global Erectile Dysfunction Treatment Devices Market has valued at USD 1.20 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.90% through 2028. Erectile Dysfunction (ED), also known as impotence, is a medical condition characterized by the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is a common issue that can affect men of all ages but becomes more prevalent with increasing age. ED can have physical and psychological causes, and it can have a significant impact on a man's quality of life and self-esteem. Erections occur when there is an increase in blood flow to the penis, causing it to become rigid and erect. This process involves a complex interplay of nerves, blood vessels, hormones, and psychological factors. ED can occur when there is a disruption in any part of this process. The diagnosis of ED typically involves a thorough medical history, a physical examination, and sometimes additional tests, such as blood tests or imaging, to identify underlying physical causes. Treatment options for ED depend on the underlying cause and may include lifestyle modifications, counseling or therapy for psychological factors, medications (such as phosphodiesterase type 5 inhibitors like Viagra), vacuum erection devices, penile implants, or in some cases, surgery.

The global population is aging, and older individuals are more likely to experience erectile dysfunction. As the proportion of elderly people increases, there is a higher demand for treatments, including medical devices. Ongoing innovations and advancements in medical device technology have led to the development of more effective and minimally invasive erectile dysfunction treatment devices, making them more appealing to both patients and healthcare providers. Growing awareness about erectile dysfunction as a medical condition, coupled with advocacy efforts and educational campaigns, encourages individuals to seek treatment and healthcare providers to offer a wider range of options, including devices. Lifestyle factors such as increased stress, poor dietary habits, and sedentary living can contribute to erectile dysfunction. As these lifestyle-related issues persist, the demand for treatment options, including devices, remains strong.

Key Market Drivers

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.20 Billion
Market Size 2028USD 1.87 Billion
CAGR 2023-20287.90%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Advancements in Medical Device Technology

Advancements in medical device technology have significantly improved the options available for the treatment of erectile dysfunction (ED). These innovations aim to provide more effective, less invasive, and patient-friendly solutions. Surgical techniques for implanting penile prostheses have become more minimally invasive, leading to reduced recovery times and improved patient outcomes. Modern penile implants offer various options for customization, allowing healthcare providers to select the most suitable device based on the patient's anatomy and needs. Vacuum Erection Devices (VEDs) have undergone design improvements to enhance ease of use, comfort, and effectiveness. These devices are now more discreet and user-friendly. Some VEDs incorporate digital interfaces and monitoring capabilities to provide real-time feedback to patients and their healthcare providers. Advancements in shockwave therapy technology have led to the development of devices that can deliver focused shockwaves precisely to the treatment area, potentially improving efficacy and reducing side effects. Some shockwave therapy devices are now available in portable formats, making it possible for patients to receive treatment in the comfort of their homes. Devices used for intracavernous injection of medications have become more user-friendly, with features such as adjustable depth control and automatic injection mechanisms. Ongoing research is focused on developing transdermal patches and creams that can deliver medications directly to the penis, offering a less invasive alternative to injections.

Some ED treatment devices are equipped with telemedicine capabilities, allowing patients to consult with healthcare providers remotely and receive personalized treatment guidance and adjustments. Emerging technologies aim to provide sensory feedback to individuals with ED by simulating sensations of touch and arousal, enhancing the overall experience and intimacy. Neuromodulation devices, such as penile vibratory stimulators, are being developed to stimulate nerve pathways, potentially enhancing erectile function. Some devices use biomechanics to enhance the natural erection process. These may include external mechanical aids that facilitate blood flow or maintain rigidity. Ongoing research explores the use of stem cells and regenerative therapies in conjunction with medical devices to promote tissue regeneration and improve erectile function. 3D printing allows for the creation of customized implants and devices tailored to the individual's anatomy, potentially improving the effectiveness and comfort of treatment. This factor will help in the development of the Global Erectile Dysfunction Treatment Devices Market.

Rising Aging Population

Erectile dysfunction becomes more common as men age. It is estimated that the prevalence of ED increases with each decade of life. As the population ages, there is a natural increase in the number of men experiencing ED. Older individuals tend to have more frequent interactions with the healthcare system due to age-related health concerns. This increased healthcare utilization provides more opportunities for diagnosing and addressing erectile dysfunction, including the consideration of treatment devices. Many older adults today lead active and fulfilling lives well into their later years. They desire to maintain a satisfying sexual life, which can drive the demand for effective ED treatment options, including medical devices. Advances in healthcare have led to improved life expectancy. As people live longer, they may continue to engage in sexual activity and seek solutions for sexual health issues, such as ED. Some individuals continue to work and remain sexually active well past the traditional retirement age. This trend further extends the period during which individuals may seek treatment for ED. Older generations may have a growing awareness of erectile dysfunction as a medical condition that can be treated. This awareness encourages them to consult healthcare providers and explore available treatment options, including devices. With age often comes a greater willingness to seek medical advice and treatment for health concerns.

Older adults are more likely to consult healthcare professionals regarding ED, which can lead to the recommendation of treatment devices. Aging is often associated with the development of chronic health conditions such as diabetes, hypertension, and cardiovascular disease. These comorbidities can contribute to the onset or worsening of ED, prompting individuals to seek treatment. As older adults observe positive outcomes from ED treatment devices, either through their own experiences or through testimonials from peers, they may become more inclined to explore these options. Elderly individuals often have consistent access to healthcare due to Medicare or other health insurance coverage, which can facilitate consultations and treatments for ED. Maintaining a healthy and satisfying sexual relationship is important for many older couples. Partner expectations and mutual desire for addressing ED can drive individuals to seek treatment. This factor will pace up the demand of the Global Erectile Dysfunction Treatment Devices Market.

Changing Lifestyles

Modern lifestyles often involve sedentary activities, such as desk jobs and extended periods of sitting. A sedentary lifestyle is a risk factor for ED, as it can lead to obesity and poor cardiovascular health. As more people adopt sedentary habits, the prevalence of ED may increase, leading to greater demand for treatment options, including devices. Diets high in processed foods, sugar, and unhealthy fats can contribute to obesity and conditions like diabetes and hypertension, which are risk factors for ED. The adoption of unhealthy dietary habits can lead to a higher incidence of ED and the need for treatment. Modern lifestyles often involve high levels of stress, anxiety, and depression, which are associated with ED. As people cope with the stresses of contemporary life, they may seek solutions for the resulting sexual health issues. The use of tobacco, alcohol, and recreational drugs is common in some lifestyles and can contribute to ED. Individuals experiencing ED due to substance abuse may seek treatment devices as part of their efforts to overcome this condition.

Changing societal norms, including delayed marriage and parenthood, mean that individuals may engage in sexual activity at older ages. This can lead to a greater awareness of ED and a desire to seek treatment. The rise of online dating and the prevalence of social media have placed a focus on appearances and sexual performance. This can create pressure to address ED and improve one's sexual health, potentially driving demand for treatment options. Conversely, changing lifestyles also include a growing interest in physical fitness and wellness. Some individuals may adopt healthier lifestyles and explore ED treatment devices as part of their overall commitment to well-being. Increased awareness and education about sexual health and ED can prompt individuals to seek treatment for a condition they may not have previously discussed or addressed. In an era where there is often an emphasis on sexual activity as an important aspect of relationships and well-being, individuals may be more motivated to address ED to maintain fulfilling intimate lives. Advances in technology and healthcare delivery make it easier for individuals to access ED treatment options, including devices, from the privacy of their homes or through telemedicine consultations, aligning with modern lifestyles and convenience. This factor will accelerate the demand of the Global Erectile Dysfunction Treatment Devices Market.

Key Market Challenges

Alternative Treatments

Alternative treatments, such as oral medications (e.g., PDE5 inhibitors like Viagra and Cialis) and lifestyle modifications (e.g., exercise and dietary changes), compete with erectile dysfunction treatment devices for market share. Patients may choose these alternatives instead of devices. Many individuals prefer non-invasive treatments like medications or lifestyle changes over medical devices. These alternatives are often perceived as more convenient and less intimidating. Oral medications can be highly effective for many individuals with ED, and lifestyle changes can improve erectile function. This effectiveness can deter some patients from considering devices, especially if they perceive them as less effective or more cumbersome. Medications are often seen as easier to use than devices, which may require more instruction, practice, and adjustments to achieve the desired results. Some patients may opt for alternative treatments because of cost factors. Medications, especially generic versions, can be more cost-effective than medical devices. The psychological aspect of ED can influence treatment decisions. Some individuals may believe that medications offer a quicker and more "natural" solution to their condition, which can affect their choice of treatment. The stigma associated with ED can lead some individuals to choose discreet medications over devices that they may perceive as more intrusive or visible. With various alternative treatments to choose from, including medications, lifestyle changes, and even herbal supplements, patients may delay or avoid seeking device-based treatments altogether.

Cost of Treatment

Erectile dysfunction treatment devices can be relatively expensive, making them unaffordable for some patients, especially those without adequate health insurance coverage or financial resources. In many regions, health insurance coverage for erectile dysfunction treatment devices can be limited or nonexistent, leaving patients to bear the full cost of these devices out-of-pocket. Patients may be price-sensitive and opt for less expensive treatment alternatives, such as oral medications, rather than invest in a device that they perceive as costly. Patients and healthcare providers often conduct cost-benefit analyses when considering treatment options. Some may conclude that the benefits of devices do not justify the expense, particularly if alternative treatments are available. Economic factors, such as recessions or economic downturns, can impact individuals' ability to afford treatments, including erectile dysfunction devices. High device costs can be a barrier to market entry for some manufacturers, limiting competition and potentially keeping prices elevated. Cost disparities can create inequalities in access to treatment, with only those who can afford the devices having the opportunity to explore this treatment option. The cost of devices can vary significantly by region and healthcare system, further exacerbating disparities in access to treatment.

Key Market Trends

Non-Invasive Treatment Options

Many individuals prefer non-invasive treatments for erectile dysfunction due to their convenience, reduced discomfort, and avoidance of surgical procedures. Non-invasive treatments are generally less disruptive to a patient's daily life, requiring minimal recovery time and enabling a quicker return to normal activities. Non-invasive treatments typically carry fewer risks and complications compared to surgical or invasive procedures, making them a safer option for some individuals. Non-invasive treatments can be suitable for a wide range of patients, including those with milder forms of erectile dysfunction or those who prefer a less aggressive approach. Advances in non-invasive treatments have led to improved efficacy, making these options more appealing to patients and healthcare providers. Medications such as phosphodiesterase type 5 (PDE5) inhibitors (e.g., Viagra, Cialis) are widely used non-invasive treatments for erectile dysfunction. They work by increasing blood flow to the penis, helping to achieve and maintain an erection. Extracorporeal shockwave therapy (ESWT) is a non-invasive procedure that uses low-intensity shockwaves to stimulate blood flow and improve penile function. It has gained popularity as an alternative to medications or surgery. Some topical creams and gels containing medications or vasodilators can be applied directly to the penis to improve blood flow and facilitate erections.

Segmental Insights

Type Insights

In 2022, the Global Erectile Dysfunction Treatment Devices Market largest share was held by Penile Implants segment and is predicted to continue expanding over the coming years. Penile implants are often recommended for individuals with severe or refractory erectile dysfunction, where other treatment options like medications or vacuum erection devices have proven ineffective. This makes penile implants a preferred choice for addressing challenging cases. Penile implants are known for their high efficacy rates. They provide a reliable and long-lasting solution for achieving and maintaining an erection, which can significantly improve the quality of life for individuals with erectile dysfunction. Penile implants are designed to be durable and long-lasting, with some implants having a lifespan of several years or more. This durability ensures continued functionality and satisfaction for patients over an extended period. Patient satisfaction rates with penile implants are generally high. Many individuals who receive penile implants report improved sexual function and overall well-being, contributing to positive word-of-mouth and increased demand.

Cause Insights

In 2022, the Global Erectile Dysfunction Treatment Devices Market largest share was held by Vascular Disorders and Diabetes segment and is predicted to continue expanding over the coming years. Vascular disorders and diabetes are known risk factors for erectile dysfunction. Both conditions can cause damage to blood vessels and nerves, making it more challenging for men to achieve and maintain an erection. With the increasing prevalence of these conditions globally, the demand for erectile dysfunction treatment devices that address these underlying causes may have risen. Healthcare providers are increasingly emphasizing the importance of addressing the underlying causes of erectile dysfunction, such as vascular issues and diabetes. This shift in clinical focus may have led to increased interest in devices designed to target these specific conditions. Erectile dysfunction treatment devices that are tailored to address vascular disorders and diabetes-related causes may offer effective solutions for patients who have not responded well to other treatments. This effectiveness could drive demand for these devices.

End-User Insights

In 2022, the Global Erectile Dysfunction Treatment Devices Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years. Hospitals and clinics are well-equipped with specialized medical professionals, including urologists and sexual health specialists, who are trained to diagnose and treat erectile dysfunction. Patients often turn to these healthcare institutions for comprehensive evaluation and treatment options. They typically have advanced diagnostic tools and equipment that enable thorough assessments of the causes and severity of erectile dysfunction. This aids in determining the most appropriate treatment, including the use of devices. Hospitals and clinics offer a wide range of treatment options for erectile dysfunction, including both invasive and non-invasive approaches. This includes the prescription of medications, counselling, and the recommendation of medical devices when deemed necessary. In cases where other treatments are ineffective, surgical interventions such as penile implants may be recommended. Hospitals are equipped to perform these surgical procedures, making them a go-to choose for such treatments.

Regional Insights

The North America region dominates the Global Erectile Dysfunction Treatment Devices Market in 2022. North America, particularly the United States, has one of the highest healthcare expenditures in the world. This enables greater access to healthcare services and treatments, including those for erectile dysfunction. Patients in the region are more likely to seek medical treatment and devices. The region boasts advanced healthcare infrastructure, including well-equipped hospitals and specialized clinics. This infrastructure facilitates the diagnosis and treatment of erectile dysfunction, including the use of medical devices. North America has a significant aging population, and erectile dysfunction is more prevalent among older men. As the population ages, the demand for treatments, including devices, increases. Factors like obesity, diabetes, hypertension, and heart disease, which are risk factors for erectile dysfunction, are relatively common in North America. This increases the patient pool seeking treatment.

Key Market Players

Boston Scientific Corporation

Coloplast Corp.

Zephyr Surgical Implants

Owen Mumford Ltd.

Augusta Medical Systems

Storz medical AG,

The Elator AB

Timm Medical Technologies Ltd.

Alma Lasers Ltd

Futura Medical plc.

Report Scope:

In this report, the Global Erectile Dysfunction Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Erectile Dysfunction Treatment Devices Market, By Type:

  • Penile implants
  • Inflatable Implants
  • Malleable Implants
  • Vacuum constriction devices
  • Shockwave therapy
  • Others

Erectile Dysfunction Treatment Devices Market, By Cause:

  • Vascular Disorders and Diabetes
  • Neurologic disorder
  • Others

Erectile Dysfunction Treatment Devices Market, By End-User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Erectile Dysfunction Treatment Devices Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Erectile Dysfunction Treatment Devices Market.

Available Customizations:

  • Global Erectile Dysfunction Treatment Devices Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Erectile Dysfunction Treatment Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Vacuum Constriction Devices, Penile Implants, Shockwave Therapy, others)
    • 5.2.2. By Cause (Vascular Disorders and Diabetes, Neurologic disorder, others)
    • 5.2.3. By End-user (Hospital & Clinics, Ambulatory Surgery Center, others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. Asia Pacific Erectile Dysfunction Treatment Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Cause
    • 6.2.3. By End-user
    • 6.2.4. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Cause
        • 6.3.1.2.3. By End-user
    • 6.3.2. India Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Cause
        • 6.3.2.2.3. By End-user
    • 6.3.3. Australia Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Cause
        • 6.3.3.2.3. By End-user
    • 6.3.4. Japan Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type
        • 6.3.4.2.2. By Cause
        • 6.3.4.2.3. By End-user
    • 6.3.5. South Korea Erectile Dysfunction Treatment Devices Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type
        • 6.3.5.2.2. By Cause
        • 6.3.5.2.3. By End-user

7. Europe Erectile Dysfunction Treatment Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Cause
    • 7.2.3. By End-user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Cause
        • 7.3.1.2.3. By End-user
    • 7.3.2. Germany Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Cause
        • 7.3.2.2.3. By End-user
    • 7.3.3. Spain Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Cause
        • 7.3.3.2.3. By End-user
    • 7.3.4. Italy Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Cause
        • 7.3.4.2.3. By End-user
    • 7.3.5. United Kingdom Erectile Dysfunction Treatment Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Cause
        • 7.3.5.2.3. By End-user

8. North America Erectile Dysfunction Treatment Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Cause
    • 8.2.3. By End-user
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Cause
        • 8.3.1.2.3. By End-user
    • 8.3.2. Mexico Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Cause
        • 8.3.2.2.3. By End-user
    • 8.3.3. Canada Erectile Dysfunction Treatment Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Cause
        • 8.3.3.2.3. By End-user

9. South America Erectile Dysfunction Treatment Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Cause
    • 9.2.3. By End-user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Cause
        • 9.3.1.2.3. By End-user
    • 9.3.2. Argentina Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Cause
        • 9.3.2.2.3. By End-user
    • 9.3.3. Colombia Erectile Dysfunction Treatment Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Cause
        • 9.3.3.2.3. By End-user

10. Middle East and Africa Erectile Dysfunction Treatment Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Cause
    • 10.2.3. By End-user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Cause
        • 10.3.1.2.3. By End-user
    • 10.3.2. Saudi Arabia Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Cause
        • 10.3.2.2.3. By End-user
    • 10.3.3. UAE Erectile Dysfunction Treatment Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Cause
        • 10.3.3.2.3. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Erectile Dysfunction Treatment Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

  • 16.1. Boston Scientific Corporation
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (In case of listed companies)
    • 16.1.5. Recent Developments
    • 16.1.6. SWOT Analysis
  • 16.2. Coloplast Corp.
    • 16.2.1. Business Overview
    • 16.2.2. Company Snapshot
    • 16.2.3. Products & Services
    • 16.2.4. Financials (In case of listed companies)
    • 16.2.5. Recent Developments
    • 16.2.6. SWOT Analysis
  • 16.3. Zephyr Surgical Implants
    • 16.3.1. Business Overview
    • 16.3.2. Company Snapshot
    • 16.3.3. Products & Services
    • 16.3.4. Financials (In case of listed companies)
    • 16.3.5. Recent Developments
    • 16.3.6. SWOT Analysis
  • 16.4. Owen Mumford Ltd.
    • 16.4.1. Business Overview
    • 16.4.2. Company Snapshot
    • 16.4.3. Products & Services
    • 16.4.4. Financials (In case of listed companies)
    • 16.4.5. Recent Developments
    • 16.4.6. SWOT Analysis
  • 16.5. Augusta Medical Systems
    • 16.5.1. Business Overview
    • 16.5.2. Company Snapshot
    • 16.5.3. Products & Services
    • 16.5.4. Financials (In case of listed companies)
    • 16.5.5. Recent Developments
    • 16.5.6. SWOT Analysis
  • 16.6. Storz medical AG
    • 16.6.1. Business Overview
    • 16.6.2. Company Snapshot
    • 16.6.3. Products & Services
    • 16.6.4. Financials (In case of listed companies)
    • 16.6.5. Recent Developments
    • 16.6.6. SWOT Analysis
  • 16.7. Timm Medical Technologies Inc
    • 16.7.1. Business Overview
    • 16.7.2. Company Snapshot
    • 16.7.3. Products & Services
    • 16.7.4. Financials (In case of listed companies)
    • 16.7.5. Recent Developments
    • 16.7.6. SWOT Analysis
  • 16.8. The Elator AB
    • 16.8.1. Business Overview
    • 16.8.2. Company Snapshot
    • 16.8.3. Products & Services
    • 16.8.4. Financials (In case of listed companies)
    • 16.8.5. Recent Developments
    • 16.8.6. SWOT Analysis
  • 16.9. Alma Lasers Ltd
    • 16.9.1. Business Overview
    • 16.9.2. Company Snapshot
    • 16.9.3. Products & Services
    • 16.9.4. Financials (In case of listed companies)
    • 16.9.5. Recent Developments
    • 16.9.6. SWOT Analysis
  • 16.10. Futura Medical plc
    • 16.10.1. Business Overview
    • 16.10.2. Company Snapshot
    • 16.10.3. Products & Services
    • 16.10.4. Financials (In case of listed companies)
    • 16.10.5. Recent Developments
    • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer